| 1 |
35297512 | Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases. | 2022 Jun |
1 |
| 2 |
32808031 | The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation. | 2020 Aug 18 |
1 |
| 3 |
21106989 | CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP. | 2011 Feb 10 |
1 |